Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6F7Q

Human Butyrylcholinesterase complexed with N-Propargyliperidines

6F7Q の概要
エントリーDOI10.2210/pdb6f7q/pdb
分子名称Cholinesterase, SULFATE ION, CHLORIDE ION, ... (12 entities in total)
機能のキーワードalzheimer disease ad butyrylcholinesterase n-propargyliperidines, hydrolase
由来する生物種Homo sapiens (Human)
タンパク質・核酸の鎖数2
化学式量合計126208.40
構造登録者
Coquelle, N.,Knez, D.,Colletier, J.P.,Gobec, S. (登録日: 2017-12-11, 公開日: 2018-09-05, 最終更新日: 2025-10-01)
主引用文献Knez, D.,Coquelle, N.,Pislar, A.,Zakelj, S.,Jukic, M.,Sova, M.,Mravljak, J.,Nachon, F.,Brazzolotto, X.,Kos, J.,Colletier, J.P.,Gobec, S.
Multi-target-directed ligands for treating Alzheimer's disease: Butyrylcholinesterase inhibitors displaying antioxidant and neuroprotective activities.
Eur.J.Med.Chem., 156:598-617, 2018
Cited by
PubMed Abstract: The limited clinical efficacy of current symptomatic treatment and minute effect on progression of Alzheimer's disease has shifted the research focus from single targets towards multi-target-directed ligands. Here, a potent selective inhibitor of human butyrylcholinesterase was used as the starting point to develop a new series of multifunctional ligands. A focused library of derivatives was designed and synthesised that showed both butyrylcholinesterase inhibition and good antioxidant activity as determined by the DPPH assay. The crystal structure of compound 11 in complex with butyrylcholinesterase revealed the molecular basis for its low nanomolar inhibition of butyrylcholinesterase (Ki = 1.09 ± 0.12 nM). In addition, compounds 8 and 11 show metal-chelating properties, and reduce the redox activity of chelated Cu ions in a Cu-ascorbate redox system. Compounds 8 and 11 decrease intracellular levels of reactive oxygen species, and are not substrates of the active efflux transport system, as determined in Caco2 cells. Compound 11 also protects neuroblastoma SH-SY5Y cells from toxic Aβ species. These data indicate that compounds 8 and 11 are promising multifunctional lead ligands for treatment of Alzheimer's disease.
PubMed: 30031971
DOI: 10.1016/j.ejmech.2018.07.033
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.6 Å)
構造検証レポート
Validation report summary of 6f7q
検証レポート(詳細版)ダウンロードをダウンロード

252456

件を2026-04-22に公開中

PDB statisticsPDBj update infoContact PDBjnumon